Stow, MA, United States of America

Travis Matthew Stams

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 7.8

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2010-2022

Loading Chart...
Loading Chart...
7 patents (USPTO):

Title: Inventor Spotlight: Travis Matthew Stams

Introduction

Travis Matthew Stams, a talented inventor based in Stow, MA (US), has made significant contributions to the field of pharmaceuticals with a total of 7 patents to his name. His cutting-edge work in developing compounds for inhibiting the activity of SHP2 has garnered attention in the scientific community.

Latest Patents

One of his latest patents involves 1-pyridazin-/triazin-3-yl-piper(-azine)/idine/pyrolidine derivatives and compositions for inhibiting the activity of SHP2. These compounds play a crucial role in managing diseases or disorders associated with the aberrant activity of SHP2, showcasing Travis's innovation in drug development.

Career Highlights

Travis Matthew Stams is currently associated with Novartis AG, a leading pharmaceutical company known for its groundbreaking research and development. His tenure at Novartis AG has been marked by remarkable achievements in the field of drug discovery, solidifying his reputation as a brilliant mind in the industry.

Collaborations

Throughout his career, Travis has collaborated closely with esteemed colleagues, including David Weninger Barnes and Gary Mark Coppola. Together, they have worked on various projects, pushing the boundaries of pharmaceutical research and bringing novel solutions to the forefront of the industry.

Conclusion

In conclusion, Travis Matthew Stams stands out as a prolific inventor with a strong focus on innovation and scientific excellence. His groundbreaking patents and collaborations reflect his dedication to advancing the field of pharmaceuticals, and his work continues to inspire future generations of inventors in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…